Question: Pegaptanib sodium injection (brand name Macugen) is an anti-angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration (AMD), it was licensed in 2000 to EyeTech Pharmaceuticals, now called what, an American pharmaceutical company based in Long Island, New York with facilities in Colorado, New Jersey and the United Kingdom?
Sentence (from "OSI Pharmaceuticals"): Though oncology is the top priority for OSI, research and development targeting type 2 diabetes and obesity is conducted through their U.K. subsidiary Prosidion Limited.
Relevant evidence: No